Monthly Archives: December 2010

Cytokinetics ALS Drug “Helps” Patients, but Stock is Down 22%?

OK, I admit that I am probably too much of an idealist, but today’s news about Cytokinetics and its amyotropic lateral sclerosis (ALS) drug bugs me. The first story I saw has the headline, “Cytokinetics, Inc. (CYTK) Stock Plunges 21% … Continue reading






Posted in Communicating Science, Education | Tagged , , | Comments Off on Cytokinetics ALS Drug “Helps” Patients, but Stock is Down 22%?